Cargando…

Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer’s disease

Dietary and supplemental intake of the ω-3 fatty acid docosahexaenoic acid (DHA) reduces risk of Alzheimer’s disease (AD) and ameliorates symptoms. The apolipoprotein E (APOE)4 allele is the strongest risk factor for sporadic AD, exclusive of age. APOE4 carriers respond well to the DHA present in fi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Patrick, Rhonda P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Federation of American Societies for Experimental Biology 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338661/ https://www.ncbi.nlm.nih.gov/pubmed/30289748 http://dx.doi.org/10.1096/fj.201801412R

Ejemplares similares

Comparative analyses of DHA-Phosphatidylcholine and recombination of DHA-Triglyceride with Egg-Phosphatidylcholine or Glycerylphosphorylcholine on DHA repletion in n-3 deficient mice
por: Wu, Fang, et al.
Publicado: (2017)

The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease
por: Yassine, Hussein N., et al.
Publicado: (2016)

DHA brain uptake and APOE4 status: a PET study with [1-(11)C]-DHA
por: Yassine, Hussein N., et al.
Publicado: (2017)

Green Nut Oil or DHA Supplementation Restored Decreased Distribution Levels of DHA Containing Phosphatidylcholines in the Brain of a Mouse Model of Dementia
por: Islam, Ariful, et al.
Publicado: (2020)

Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE(−/−) Mice Experimental Model
por: Ruiz-Roso, María Belén, et al.
Publicado: (2018)

The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer's Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

LPC-DHA/EPA-Enriched Diets Increase Brain DHA and Modulate Behavior in Mice That Express Human APOE4
por: Scheinman, Sarah B., et al.
Publicado: (2021)

Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease
por: Patel, Kavita, et al.
Publicado: (2021)

Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
por: Heath, Rory J., et al.
Publicado: (2021)

The Influence of APOE Genotype, DHA, and Flavanol Intervention on Brain DHA and Lipidomics Profile in Aged Transgenic Mice
por: Martinsen, Anneloes, et al.
Publicado: (2023)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

Production of Structured Phosphatidylcholine with High Content of DHA/EPA by Immobilized Phospholipase A(1)-Catalyzed Transesterification
por: Li, Xiang, et al.
Publicado: (2014)

Recovery of brain DHA-containing phosphatidylserine and ethanolamine plasmalogen after dietary DHA-enriched phosphatidylcholine and phosphatidylserine in SAMP8 mice fed with high-fat diet
por: Zhao, Ying-Cai, et al.
Publicado: (2020)

DHA-Enriched Fish Oil Ameliorates Deficits in Cognition Associated with Menopause and the APOE4 Genotype in Rodents
por: Pontifex, Matthew G., et al.
Publicado: (2022)

Roles of ApoE4 on the Pathogenesis in Alzheimer’s Disease and the Potential Therapeutic Approaches
por: Sun, Yu-Ying, et al.
Publicado: (2023)

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect
por: Ferreira, Inês, et al.
Publicado: (2022)

ApoE4: an emerging therapeutic target for Alzheimer’s disease
por: Safieh, Mirna, et al.
Publicado: (2019)

Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness
por: Bantugan, Mikaila Ann, et al.
Publicado: (2023)

Role of APOE and Age at Enrollment in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
por: Drye, Lea T., et al.
Publicado: (2012)

Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
por: Norwitz, Nicholas G., et al.
Publicado: (2021)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
por: Wolfe, Cody M., et al.
Publicado: (2018)

Building in vitro models of the brain to understand the role of APOE in Alzheimer’s disease
por: Pinals, Rebecca L, et al.
Publicado: (2022)

The Role of Upregulated APOE in Alzheimer’s Disease Etiology
por: Gottschalk, William K, et al.
Publicado: (2016)

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
por: Fernández-Calle, Rosalía, et al.
Publicado: (2022)

Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
por: Bu, Guojun, et al.
Publicado: (2013)

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review
por: Emrani, Sheina, et al.
Publicado: (2020)

Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
por: Pires, Mariana, et al.
Publicado: (2023)

The Role of Resolvins: EPA and DHA Derivatives Can Be Useful in the Prevention and Treatment of Ischemic Stroke
por: Tułowiecka, Nikola, et al.
Publicado: (2020)

APOE2 is associated with longevity independent of Alzheimer’s disease
por: Shinohara, Mitsuru, et al.
Publicado: (2020)

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
por: Raulin, Ana-Caroline, et al.
Publicado: (2022)

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease
por: Kim, Min, et al.
Publicado: (2017)

Improvement of retinal function in Alzheimer disease-associated retinopathy by dietary lysophosphatidylcholine-EPA/DHA
por: Sugasini, Dhavamani, et al.
Publicado: (2023)

Serum unsaturated phosphatidylcholines predict longitudinal basal forebrain degeneration in Alzheimer’s disease
por: Shanks, Hayley R C, et al.
Publicado: (2022)

The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease
por: Fernandez, Celia G., et al.
Publicado: (2019)

A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer’s Disease
por: Jayatunga, Dona P. W., et al.
Publicado: (2022)

The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
por: Stocker, Hannah, et al.
Publicado: (2018)

Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice
por: Moser, V. Alexandra, et al.
Publicado: (2017)

The Synergistic Effects of APOE Genotype and Obesity on Alzheimer’s Disease Risk
por: Jones, Nahdia S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_32l3e8opit3tfjj4hdggsugst4